Alkermes PLC has a consensus price target of $37.6 based on the ratings of 17 analysts. The high is $52 issued by Deutsche Bank on March 27, 2025. The low is $26 issued by JP Morgan on October 25, 2024. The 3 most-recent analyst ratings were released by Deutsche Bank, RBC Capital, and Goldman Sachs on March 27, 2025, March 13, 2025, and February 14, 2025, respectively. With an average price target of $41.33 between Deutsche Bank, RBC Capital, and Goldman Sachs, there's an implied 53.09% upside for Alkermes PLC from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/27/2025 | Buy Now | 92.59% | Deutsche Bank | David Hoang35% | $40 → $52 | Maintains | Buy | Get Alert |
03/13/2025 | Buy Now | 48.15% | RBC Capital | Leonid Timashev35% | → $40 | Initiates | → Sector Perform | Get Alert |
03/04/2025 | Buy Now | — | UBS | Ashwani Verma40% | — | Upgrade | Sell → Neutral | Get Alert |
02/14/2025 | Buy Now | 18.52% | Goldman Sachs | Chris Shibutani55% | $30 → $32 | Maintains | Buy | Get Alert |
02/13/2025 | Buy Now | 70.37% | HC Wainwright & Co. | Douglas Tsao50% | $46 → $46 | Reiterates | Neutral → Neutral | Get Alert |
02/11/2025 | Buy Now | 48.15% | Deutsche Bank | David Hoang35% | → $40 | Initiates | → Buy | Get Alert |
11/13/2024 | Buy Now | 48.15% | Mizuho | Uy Ear60% | $35 → $40 | Maintains | Outperform | Get Alert |
11/05/2024 | Buy Now | 33.33% | Stifel | Paul Matteis41% | $25 → $36 | Upgrade | Hold → Buy | Get Alert |
10/25/2024 | Buy Now | 11.11% | Goldman Sachs | Chris Shibutani55% | $32 → $30 | Maintains | Buy | Get Alert |
10/25/2024 | Buy Now | 59.26% | Cantor Fitzgerald | Charles Duncan68% | $48 → $43 | Maintains | Overweight | Get Alert |
10/25/2024 | Buy Now | -3.7% | JP Morgan | Jessica Fye63% | $32 → $26 | Maintains | Neutral | Get Alert |
10/25/2024 | Buy Now | 37.04% | Piper Sandler | David Amsellem69% | $38 → $37 | Reiterates | Overweight → Overweight | Get Alert |
10/25/2024 | Buy Now | 37.04% | HC Wainwright & Co. | Douglas Tsao50% | $37 → $37 | Reiterates | Neutral → Neutral | Get Alert |
10/14/2024 | Buy Now | 37.04% | HC Wainwright & Co. | Douglas Tsao50% | $37 → $37 | Reiterates | Neutral → Neutral | Get Alert |
10/10/2024 | Buy Now | 77.78% | Cantor Fitzgerald | Charles Duncan68% | $48 → $48 | Reiterates | Overweight → Overweight | Get Alert |
09/16/2024 | Buy Now | 77.78% | Cantor Fitzgerald | Charles Duncan68% | $48 → $48 | Reiterates | Overweight → Overweight | Get Alert |
07/25/2024 | Buy Now | 77.78% | Cantor Fitzgerald | Charles Duncan68% | $48 → $48 | Reiterates | Overweight → Overweight | Get Alert |
07/25/2024 | Buy Now | 18.52% | JP Morgan | Jessica Fye63% | $31 → $32 | Maintains | Neutral | Get Alert |
07/25/2024 | Buy Now | 40.74% | Baird | Joel Beatty64% | $37 → $38 | Maintains | Outperform | Get Alert |
07/25/2024 | Buy Now | 37.04% | HC Wainwright & Co. | Douglas Tsao50% | $35 → $37 | Maintains | Neutral | Get Alert |
07/15/2024 | Buy Now | 14.81% | JP Morgan | Jessica Fye63% | $32 → $31 | Maintains | Neutral | Get Alert |
06/17/2024 | Buy Now | 25.93% | TD Cowen | Joseph Thome28% | → $34 | Initiates | → Buy | Get Alert |
06/04/2024 | Buy Now | 29.63% | HC Wainwright & Co. | Douglas Tsao50% | $35 → $35 | Reiterates | Neutral → Neutral | Get Alert |
05/23/2024 | Buy Now | 77.78% | Cantor Fitzgerald | Charles Duncan68% | $43 → $48 | Maintains | Overweight | Get Alert |
05/02/2024 | Buy Now | 29.63% | HC Wainwright & Co. | Douglas Tsao50% | $35 → $35 | Reiterates | Neutral → Neutral | Get Alert |
04/19/2024 | Buy Now | 29.63% | HC Wainwright & Co. | Douglas Tsao50% | $35 → $35 | Reiterates | Neutral → Neutral | Get Alert |
04/09/2024 | Buy Now | 85.19% | Jefferies | Akash Tewari43% | $42 → $50 | Maintains | Buy | Get Alert |
04/01/2024 | Buy Now | 44.44% | Piper Sandler | David Amsellem69% | $39 → $39 | Reiterates | Overweight → Overweight | Get Alert |
03/19/2024 | Buy Now | 37.04% | Baird | Joel Beatty64% | → $37 | Initiates | → Outperform | Get Alert |
02/20/2024 | Buy Now | -7.41% | UBS | Ashwani Verma40% | $25 → $25 | Downgrade | Neutral → Sell | Get Alert |
02/16/2024 | Buy Now | 44.44% | Piper Sandler | David Amsellem69% | $35 → $39 | Maintains | Overweight | Get Alert |
01/02/2024 | Buy Now | 7.41% | B of A Securities | Jason Gerberry61% | $27 → $29 | Maintains | Neutral | Get Alert |
11/20/2023 | Buy Now | 22.22% | JP Morgan | Jessica Fye63% | → $33 | Reinstates | → Neutral | Get Alert |
10/27/2023 | Buy Now | 29.63% | Piper Sandler | David Amsellem69% | $37 → $35 | Maintains | Overweight | Get Alert |
10/26/2023 | Buy Now | 29.63% | Mizuho | Uy Ear60% | $37 → $35 | Maintains | Buy | Get Alert |
10/24/2023 | Buy Now | — | Evercore ISI Group | Umer Raffat43% | — | Upgrade | In-Line → Outperform | Get Alert |
10/17/2023 | Buy Now | 14.81% | UBS | Ashwani Verma40% | → $31 | Initiates | → Neutral | Get Alert |
07/27/2023 | Buy Now | 25.93% | HC Wainwright & Co. | Douglas Tsao50% | → $34 | Reiterates | Neutral → Neutral | Get Alert |
06/07/2023 | Buy Now | 37.04% | Piper Sandler | David Amsellem69% | $35 → $37 | Maintains | Overweight | Get Alert |
06/06/2023 | Buy Now | 22.22% | Stifel | Paul Matteis41% | $31 → $33 | Maintains | Hold | Get Alert |
04/27/2023 | Buy Now | 33.33% | Mizuho | Uy Ear60% | $37 → $36 | Maintains | Buy | Get Alert |
04/27/2023 | Buy Now | 25.93% | HC Wainwright & Co. | Douglas Tsao50% | $32 → $34 | Maintains | Neutral | Get Alert |
04/25/2023 | Buy Now | 14.81% | JP Morgan | Jessica Fye63% | $29 → $31 | Maintains | Neutral | Get Alert |
04/11/2023 | Buy Now | 37.04% | Mizuho | Uy Ear60% | $36 → $37 | Maintains | Buy | Get Alert |
02/17/2023 | Buy Now | 18.52% | HC Wainwright & Co. | Douglas Tsao50% | → $32 | Reiterates | → Neutral | Get Alert |
12/06/2022 | Buy Now | 7.41% | JP Morgan | Jessica Fye63% | $33 → $29 | Maintains | Neutral | Get Alert |
11/22/2022 | Buy Now | 33.33% | Mizuho | Uy Ear60% | $34 → $36 | Maintains | Buy | Get Alert |
11/03/2022 | Buy Now | 11.11% | Piper Sandler | David Amsellem69% | $26 → $30 | Upgrade | Neutral → Overweight | Get Alert |
10/14/2022 | Buy Now | -7.41% | B of A Securities | Jason Gerberry61% | $27 → $25 | Upgrade | Underperform → Neutral | Get Alert |
08/16/2022 | Buy Now | -3.7% | Piper Sandler | David Amsellem69% | → $26 | Initiates | → Neutral | Get Alert |
07/28/2022 | Buy Now | 25.93% | Mizuho | Vamil Divan74% | $36 → $34 | Maintains | Buy | Get Alert |
04/28/2022 | Buy Now | — | SVB Leerink | Marc Goodman73% | $24 → $27 | Maintains | Market Perform | Get Alert |
04/28/2022 | Buy Now | 18.52% | HC Wainwright & Co. | Douglas Tsao50% | $30 → $32 | Maintains | Neutral | Get Alert |
04/21/2022 | Buy Now | -7.41% | SVB Leerink | Marc Goodman73% | $24 → $25 | Maintains | Market Perform | Get Alert |
04/20/2022 | Buy Now | 29.63% | Goldman Sachs | Chris Shibutani55% | → $35 | Initiates | → Buy | Get Alert |
The latest price target for Alkermes (NASDAQ:ALKS) was reported by Deutsche Bank on March 27, 2025. The analyst firm set a price target for $52.00 expecting ALKS to rise to within 12 months (a possible 92.59% upside). 26 analyst firms have reported ratings in the last year.
The latest analyst rating for Alkermes (NASDAQ:ALKS) was provided by Deutsche Bank, and Alkermes maintained their buy rating.
The last upgrade for Alkermes PLC happened on March 4, 2025 when UBS raised their price target to N/A. UBS previously had a sell for Alkermes PLC.
The last downgrade for Alkermes PLC happened on February 20, 2024 when UBS changed their price target from $25 to $25 for Alkermes PLC.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alkermes, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alkermes was filed on March 27, 2025 so you should expect the next rating to be made available sometime around March 27, 2026.
While ratings are subjective and will change, the latest Alkermes (ALKS) rating was a maintained with a price target of $40.00 to $52.00. The current price Alkermes (ALKS) is trading at is $27.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.